Nodal disease burden and outcome of medullary thyroid carcinoma

Head Neck. 2021 Feb;43(2):577-584. doi: 10.1002/hed.26511. Epub 2020 Oct 27.

Abstract

Background: Medullary thyroid carcinoma (MTC) is a rare malignancy with high incidence of cervical lymph node (CLN) metastasis. We investigated the impact of nodal disease burden on survival.

Methods: We searched the National Cancer Database for MTC patients treated surgically. Impact of nodal metastasis on survival was analyzed using Cox univariable and multivariable regression.

Results: We identified 2627 patients from 2004 to 2015. Positive CLNs were identified in 1433 (54.5%), and 542 (20.6%) had >10 CLN+. Overall survival was 94.5% and 89.6% at 3 and 5 years. Patients with 11 to 20 CLN+ had significantly worse survival than patients with 1 to 10 CLN+ in univariable and multivariable analyses (HR = 3.56 (2.31-5.50) vs 2.26 (1.60-3.20); P < .0001). The ratio of positive to dissected CLN was associated with overall survival.

Conclusions: Higher burden of nodal disease is associated with worse survival in MTC. The number of positive nodes could be a valuable prognosticator in addition to the current staging system.

MeSH terms

  • Carcinoma, Neuroendocrine* / surgery
  • Cost of Illness
  • Humans
  • Lymph Nodes / pathology
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Neoplasm Staging
  • Prognosis
  • Thyroid Neoplasms* / pathology
  • Thyroid Neoplasms* / surgery